Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-10-08 2:22 pm Purchase |
2021-09-30 | 13G | aTyr Pharma, Inc. LIFE |
FEDERATED HERMES INC. FHI |
5,222,250 19.860% |
3,607,250 (+223.36%) |
Filing History |
| 2021-09-27 5:14 pm Purchase |
2021-09-16 | 13G | aTyr Pharma, Inc. ATYR |
Venrock Healthcare Capital Partners II, L.P. | 1,815,000 6.700% |
1,815,000 (New Position) |
Filing History |
| 2021-09-17 3:00 pm Purchase |
2021-09-16 | 13G | aTyr Pharma, Inc. ATYR |
Ikarian Capital LLC | 888,580 5.300% |
888,580 (New Position) |
Filing History |
| 2021-09-17 12:31 pm Purchase |
2021-09-13 | 13G | aTyr Pharma, Inc. ATYR |
TANG CAPITAL PARTNERS LP | 1,063,453 6.300% |
1,063,453 (New Position) |
Filing History |
| 2021-07-12 12:07 pm Purchase |
2021-07-09 | 13G | aTyr Pharma, Inc. ATYR |
FMR CORP | 1,675,880 10.432% |
91,196 (+5.75%) |
Filing History |
| 2021-04-12 1:05 pm Purchase |
2021-04-09 | 13G | aTyr Pharma, Inc. ATYR |
FMR CORP | 1,584,684 9.897% |
56,866 (+3.72%) |
Filing History |
| 2021-04-09 2:14 pm Unchanged |
2021-03-31 | 13G | aTyr Pharma, Inc. LIFE |
FEDERATED HERMES INC. FHI |
1,615,000 10.090% |
0 (Unchanged) |
Filing History |
| 2021-02-17 06:10 am Purchase |
2021-02-12 | 13G | aTyr Pharma, Inc. LIFE |
Aspire Capital Fund LLC | 1,312,537 9.150% |
1,312,537 (New Position) |
Filing History |
| 2021-02-16 11:21 am Purchase |
2020-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Alyeska Investment Group, L.P. | 842,554 8.300% |
842,554 (New Position) |
Filing History |
| 2021-02-12 7:29 pm Sale |
2020-12-31 | 13G | aTyr Pharma, Inc. LIFE |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-816,728 (Position Closed) |
Filing History |
| 2021-02-12 3:14 pm Sale |
2020-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Altium Capital Management LLC | 332,258 3.200% |
-142,742 (-30.05%) |
Filing History |
| 2021-02-12 1:17 pm Purchase |
2020-12-31 | 13G | aTyr Pharma, Inc. LIFE |
FEDERATED HERMES INC. FHI |
1,615,000 15.860% |
1,019,928 (+171.40%) |
Filing History |
| 2021-02-10 6:20 pm Purchase |
2020-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Renaissance Technologies LLC | 319,130 3.130% |
119,210 (+59.63%) |
Filing History |
| 2021-02-08 10:15 am Purchase |
2021-02-05 | 13G | aTyr Pharma, Inc. ATYR |
FMR CORP | 1,527,818 14.999% |
1,036,369 (+210.88%) |
Filing History |
| 2021-01-21 5:48 pm Sale |
2020-12-31 | 13G | aTyr Pharma, Inc. LIFE |
Domain Partners VIII L.P. | 89,425 0.900% |
-39,705 (-30.75%) |
Filing History |